Contact
Please use this form to send email to PR contact of this press release:
GSK and Theravance announce submission to US regulatory authorities for fluticasone furoate/vilanterol in asthma
TO:
Please use this form to send email to PR contact of this press release:
GSK and Theravance announce submission to US regulatory authorities for fluticasone furoate/vilanterol in asthma
TO: